| 名称 | 净值 | 日增长率 |
| 以下为热门基金 | ||
| 名称 | 净值 | 日增长率 |
| 红土创新科技创新股票(LOF) | 0.8095 | 2.86% |
| 华安沪港深机会灵活配置混合 | 1.0990 | 2.71% |
| 大摩万众创新混合A | 0.5411 | 2.64% |
| 大摩万众创新混合C | 0.5375 | 2.62% |
| 汇添富国证港股通创新药ETF发起式联接C | 0.9760 | 2.40% |
| 汇添富国证港股通创新药ETF发起式联接A | 0.9764 | 2.39% |
| 汇丰晋信龙腾混合A | 0.9435 | 2.34% |
| 北信瑞丰健康生活主题灵活配置 | 0.8390 | 2.32% |
| 鹏华沪深港新兴成长混合A | 0.9679 | 2.32% |
| 汇添富恒生香港上市生物科技ETF发起式联接(QDII)A | 0.9063 | 2.21% |
| 名称 | 净值 | 日增长率 |
| 人保添益6个月定开C | 1.0 | 14.03% |
| 人保添益6个月定开A | 1.0 | 13.75% |
| 人保沪深300C | 1.1906 | 0.56% |
| 人保沪深300A | 1.1909 | 0.56% |
| 人保量化锐进混合A | 0.6391 | 0.33% |
| 名称 | 万份收益 | 7日年化 |
| 人保货币A | 0.4242 | 1.57% |
| 人保货币B | 0.4242 | 1.57% |
| 名称 | 日增长率 | 操作 |
| 易方达新兴成长混合 | -0.23% | |
| 鹏华中证国防指数(LOF)A | 0.63% | |
| 兴全有机增长混合 | -0.27% | |
| 名称 | 万份收益 | 操作 |
| 诺安聚鑫宝货币A | 0.4493 |
| 名称 | 成立以来收益 | 操作 |
（单位：万元）
| 报告期 | 收入合计 | 股票收入 | 占比 | 债券收入 | 占比 | 股利收入 | 占比 |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | -11.41 | -48.21 | 422.64% | 93.77 | -822.05% | 53.37 | -467.90% |
| 2023-06-30 | 305.92 | -37.40 | -12.23% | 50.20 | 16.41% | 23.92 | 7.82% |
| 2022-12-31 | 46.72 | 16.39 | 35.08% | -18.09 | -38.71% | 53.15 | 113.76% |
| 2022-06-30 | 50.21 | 27.31 | 54.39% | 51.73 | 103.04% | 23.66 | 47.13% |
| 2021-12-31 | 252.63 | 200.50 | 79.36% | -34.27 | -13.57% | 32.03 | 12.68% |
| 2021-06-30 | 81.97 | 0.72 | 0.88% | -3.20 | -3.91% | 7.78 | 9.49% |
| 2020-12-31 | 411.58 | 275.04 | 66.83% | -21.36 | -5.19% | 12.14 | 2.95% |
| 2020-06-30 | 175.64 | 203.45 | 115.83% | 5.31 | 3.02% | 5.08 | 2.89% |
| 2019-12-31 | 525.83 | 379.49 | 72.17% | -84.31 | -16.03% | 29.35 | 5.58% |
| 2019-06-30 | 273.14 | 6.03 | 2.21% | -70.88 | -25.95% | 10.10 | 3.70% |
| 2018-12-31 | 115.71 | -315.22 | -272.42% | 113.57 | 98.15% | 39.85 | 34.44% |
| 2018-06-30 | 104.58 | -70.12 | -67.05% | 14.52 | 13.88% | 23.33 | 22.31% |
